期刊文献+

早、晚服用施慧达对原发性高血压疗效比较 被引量:1

Effects of taking levamlodipine in the morning and night on primary hypertension
下载PDF
导出
摘要 目的评价早、晚服用施慧达对原发性高血压的降压疗效及毒副反应。方法将原发性高血压患者68例随机分为两组(分别命名为晨组与晚组),按2.5~5.0mg/d剂量分别于早餐或晚餐0.5h后口服施慧达4周,观察治疗前后降压疗效。结果与治疗前相比,两组对原发性高血压均具有显著降压效果,总有效率分别为85%、86%,但组间比较无统计学差异,两组中均未见有不良事件的发生。结论早、晚服用施慧达对原发性高血压均具有良好的降压效果,且均不易发生不良事件。 Objective To investigate the effects of Shihuida (levamlodipine) taken in the morning or night on primary hypertension. Methods 68 primary hypertension patients were divided into 2 groups randomly (named as morning group and night group respectively). Shihuida was taken orally at a dose of 2. 5-5.0 mg/d 0. 5 h later after breakfast or dinner everyday during four weeks and its depressurization effect was examined after treatment. Results The results showed that taking Shihuida either at morning or evening could significantly lower patients' blood pressure,which the total effective rates was 85% ,86% respectively,no significant differences were observed between the 2 groups,however. It was also showed that no side-effect occurred during our treatment period. Conclusion Taking Shishuida both in the morning or evening cart significantly decrease blood pressure of primary hypertension patients without side-effect.
出处 《中国实用医药》 2008年第7期30-31,共2页 China Practical Medicine
关键词 施慧达 原发性高血压 血压 Shihuida Primary hypertension Blood pressure
  • 相关文献

参考文献3

二级参考文献21

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2李秦予,刘海英,张俊芳,贾海燕,宋猛,杨红照.高血压性心力衰竭病人左心室构型变化的临床特点[J].中西医结合心脑血管病杂志,2005,3(8):696-698. 被引量:7
  • 3[2]Doller CT. Clinical pharmarcolgy of calcium antigonist [J]. Am J Hypertens, 1991, 4: 88-95.
  • 4[3]Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the international nifedipine GITS study: Intervention as a goal in hypertension treatment (INSITGHT) [J]. Lancet, 2000, 356:366-372.
  • 5[4]The ALLHAT officers and coordinators for the ALLHAT collaborative research group. Majors outcomes in High-risk hypertensive patients randomised to ACE inhibitor a calcium channel Blocker VS Diuretic-The Antihypertensive and lipidlowering treatment to prevent heart attack trial (ALLHAT) [J].JAMA, 2002, 288: 2981-2997.
  • 6[9]Jost S,Deckers JW,Nikuttap,et al. International nifedipine trial on antiatherosclerotic therapy[J]. Eur Heart J,1994,15:648.
  • 7The Joint National committeen on Prevetion,Detection,Elaluation and Treatment of High Blood Pressure.The sixth report of the Joint National Committee on prevention,detection,evaluation,and treatment of high blood pressure[J].Arch Inter Med,1997,157:2413.
  • 8ARROWSMITH J E,CAMPBELL S F,CROSS P E,et al.Long-acting dihydropyridine calcium antagonists.1,2-alkoxymethel derivatives incorporating basic substituents[J].J Med Chem,1986,29:1696-1702.
  • 9陆振兴.波依定治疗高血压的临床观察[J].国外医学(心血管疾病分册),1998,25(5):295-296. 被引量:6
  • 10张翔,乌若丹,张彤,姜玲,徐小南.氨氯地平对高血压病人左室肥厚和心功能的影响[J].中国现代医学杂志,1999,9(6):20-21. 被引量:3

共引文献11

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部